• Advancing R&D for chronic diseases with AI: A conversation with Novo Nordisk’s CSO

  • Sep 18 2024
  • Length: 26 mins
  • Podcast

Advancing R&D for chronic diseases with AI: A conversation with Novo Nordisk’s CSO

Listen for free

View show details

  • Summary

  • Marcus Schindler, chief scientific officer, and head of research and early development at Novo Nordisk, shares the ways in which he's leading the company’s efforts to embrace external innovation and expand into new therapeutic areas with AI as a powerful catalyst for progress with McKinsey colleagues Alex Devereson and Nav Nagra.

    Learn more about the McKinsey R&D practice here.

    See www.mckinsey.com/privacy-policy for privacy information
    Show More Show Less
Show More Show Less

What listeners say about Advancing R&D for chronic diseases with AI: A conversation with Novo Nordisk’s CSO

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.